Lantern Pharma gains FDA IND clearance for LP-284 to treat non-Hodgkin's lymphoma
Accuray launches global training center at Madison HQ for advanced radiotherapy education
Cantargia AB secures USD1.1m US grant for nadunolimab leukaemia clinical trial
RedHill receives FDA sNDA approval for Talicia with improved dosing regimen
Samsung Biologics signs new contract with Bristol Myers Squibb
Phanes Therapeutics adds Professor Shun Lu to Clinical Advisory Board
Charles River and Related Sciences collaborate to use Logica for AI-enabled drug discovery
Synaffix BV signs licensing agreement with ABL Bio
NanoString Technologies introduces GeoMx IO Proteome Atlas (IPA) For spatial proteomics
Dewpoint Therapeutics collaborates with Chemify
Pierre Fabre Laboratories acquires Vertical Bio AG
Beactica Therapeutics adds new members to preclinical development team
MaaT Pharma and Skyepharma complete Europe's largest microbiome manufacturing facility
IDEAYA Biosciences commences phase one monotherapy expansion in IDE161 trial